<DOC>
	<DOC>NCT00889291</DOC>
	<brief_summary>Post market observational survey of a vascular access device for access-challenged patients. Data collection efforts focused on patient medical and access history and implant procedure results.</brief_summary>
	<brief_title>HeRO Vascular Access Device Post Market Procedural Survey Protocol</brief_title>
	<detailed_description>Evaluation Design: This is a multi-center post market observational survey designed to collect procedural data on a minimum of 50 HeRO™ patients in the commercialization phase. Data will be collected retrospectively for patients already implanted with the HeRO™ device in the commercialization phase or prospectively for patients that receive the HeRO™ Device during the data collection period. No special patient screening, testing, or procedures are required. There is no required patient follow-up. Subject Population: Any patients the investigator deems/deemed eligible for HeRO™ implant with complete procedural data are eligible for inclusion in this post market observational survey. Endpoints: None Inclusion/Exclusion Criteria: There are no formal screening criteria other than patients must have all required procedural data points available for recording on the case report form.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>End stage renal disease</keyword>
	<keyword>Bacteremia</keyword>
	<keyword>HeRO Vascular Access Device</keyword>
	<keyword>Access challenged</keyword>
	<keyword>Catheter dependent</keyword>
	<keyword>End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population</keyword>
</DOC>